Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid.
Arvee Laboratories (India) Ltd. (ARVEE) is listed on the NSE in the Basic Materials sector, Specialty Chemicals industry. The ARVEE share price is ₹235.07 (+8.51% today), with a market capitalisation of ₹3B and a price-to-earnings (P/E) ratio of 63.9. MarketRipple tracks the ARVEE investment thesis, the ripple-chain impact of market events on Arvee Laboratories (India) Ltd., and the Basic Materials sector outlook.
Open
₹236.90
High
₹238.83
Low
₹228.00
Prev. Close
₹216.63
52W High
₹290.78
52W Low
₹129.11
Day range
₹228.00–₹238.83
52-week range
₹129.11–₹290.78
Volume
7K
P/E
63.9
ROE
19.0%
D/E
0.03
Margin
10.5%
Arvee Laboratories (India) Ltd. (NSE: ARVEE) is currently trading at ₹235.07 (+8.51%).
Arvee Laboratories (India) Ltd.'s market capitalization is ₹3B.
Arvee Laboratories (India) Ltd.'s price-to-earnings (P/E) ratio is 63.9.
Arvee Laboratories (India) Ltd. operates in the Basic Materials sector (Specialty Chemicals).